Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Bioject Medical Technologies Inc

+ Add to Watchlist


0.1045 USD 0.0202 16.20%

As of 20:10:00 ET on 03/27/2015.

Snapshot for Bioject Medical Technologies Inc (BJCT)

Open: 0.1045 Day's Range: 0.1045 - 0.1045 Volume: 170
Previous Close: 0.1247 52wk Range: 0.0750 - 0.3500 1-Yr Rtn: -34.71%

Stock Chart for BJCT

No chart data available.
  • BJCT:US 0.1045
  • 1D
  • 1M
  • 1Y
Interactive BJCT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BJCT

Current P/E Ratio (ttm) 10.4460
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) 0.0100
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 9.02
Shares Outstanding (M) 86.35
30 Day Average Volume 13,645
Price/Book (mrq) -
Price/Sale (ttm) 0.2158
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BJCT

No data available

Company Profile & Key Executives for BJCT

Bioject Medical Technologies Inc. develops, manufactures, and markets jet injection systems for needle-free drug delivery. The Company's Biojector 2000 allows healthcare professionals to inject medications through the skin without a needle. Bioject sells its products directly to healthcare providers and licenses its technology to pharmaceutical and biotechnology companies.

Mark LogomasiniPresident/CEOTony K ChowCFO/Secretary
Richard R StoutExec VP/Chief Medical OfficerChris PughVP:Business Development
More Company Profile & Key Executives for BJCT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil